Corneal Transplant Surgery: Types and Outcomes

More than 49,000 corneal transplants are performed each year in the United States, making the cornea the most commonly transplanted tissue in the human body (Eye Bank Association of America, 2022). Despite that volume, the procedure remains remarkably under-discussed outside ophthalmology circles — partly because outcomes have improved so dramatically over the past two decades that the surgery has become, in a sense, quietly routine. But "routine" doesn't mean simple, and the choice of transplant technique matters enormously for visual recovery, rejection risk, and long-term graft survival.

Why Corneal Transplants Are Needed

The cornea — that clear, dome-shaped front surface of the eye — accounts for roughly two-thirds of the eye's total refractive power. When it becomes clouded, scarred, or misshapen, vision deteriorates in ways that glasses or contact lenses cannot fully correct. The leading indications for corneal transplantation include Fuchs' endothelial dystrophy, keratoconus, corneal scarring from infection or trauma, and prior graft failure (National Eye Institute). Pseudophakic bullous keratopathy — corneal swelling following cataract surgery — also remains a significant indication, though improved cataract surgical techniques have reduced its prevalence.

Types of Corneal Transplant

The field has moved decisively away from one-size-fits-all full-thickness grafts. Modern corneal surgery follows a "replace only what's broken" philosophy, selectively transplanting the diseased layer while leaving healthy tissue intact.

Penetrating Keratoplasty (PK)

The traditional full-thickness transplant replaces all five layers of the cornea with donor tissue. PK was the standard approach for decades and remains appropriate when disease affects multiple corneal layers — deep stromal scarring, for example, or advanced keratoconus with significant thinning. Sutures typically remain in place for 12 to 18 months, and visual recovery can take a year or longer. The 5-year graft survival rate for first-time PK is approximately 90%, though this drops with repeat transplants and in vascularized corneas (American Academy of Ophthalmology).

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

DSAEK replaces only the innermost endothelial layer along with a thin layer of stroma. It became the dominant procedure for Fuchs' dystrophy and other endothelial diseases during the 2000s. The advantages over PK are substantial: a smaller incision, faster visual recovery (typically 3 to 6 months), and a dramatically reduced risk of traumatic wound dehiscence. Rejection rates run between 6% and 14% over the first two years, depending on the study population (Cornea Society).

Descemet Membrane Endothelial Keratoplasty (DMEK)

DMEK takes the selective approach one step further, transplanting only the Descemet membrane and its endothelial cell layer — tissue roughly 10 to 15 micrometers thick. That's thinner than a human hair. The payoff is faster visual rehabilitation and better final acuity compared with DSAEK; a multicenter study published in Ophthalmology found that 79% of DMEK patients achieved 20/25 or better by 6 months, compared with 50% of DSAEK patients (Guerra FP et al., Ophthalmology, 2011). The trade-off: DMEK tissue is more technically demanding to handle, and rebubbling rates (a secondary procedure to reattach partially detached grafts) range from 4% to 30% depending on surgeon experience.

Deep Anterior Lamellar Keratoplasty (DALK)

DALK replaces the front portion of the cornea — epithelium and stroma — while preserving the patient's own endothelium. This technique suits conditions like keratoconus and anterior stromal scarring where the endothelium is healthy. By keeping host endothelium intact, DALK essentially eliminates endothelial rejection, the most common cause of graft failure in PK. Long-term graft survival rates for DALK approach 95% at 5 years in uncomplicated cases (Johns Hopkins Wilmer Eye Institute).

Outcomes and Graft Survival

Graft survival depends on the underlying diagnosis, the transplant technique, and patient-specific risk factors. The Australian Corneal Graft Registry — one of the largest prospective registries, tracking over 30,000 grafts — reports a median PK graft survival exceeding 17 years for keratoconus, but closer to 7 years for regrafts after prior failure (Flinders University, Australian Corneal Graft Registry). Endothelial keratoplasty techniques show comparable or superior short-term survival, though long-term data beyond 10 years remains limited given how recently DSAEK and DMEK were widely adopted.

Immunologic rejection is the leading cause of graft failure and occurs in approximately 10% of low-risk corneal transplants over a lifetime. High-risk eyes — those with vascularized beds, prior graft rejection, or concurrent ocular surface disease — face rejection rates of 50% or higher without immunosuppressive therapy (NEI). Topical corticosteroids remain the first-line prophylaxis against rejection, often continued for years after surgery.

Emerging Directions

Cell-injection therapy, where cultured donor endothelial cells are injected directly into the anterior chamber, has shown promise in a Japanese trial involving 11 patients with bullous keratopathy, with corneal clarity restored in all participants at 24 months (Kinoshita S et al., New England Journal of Medicine, 2018). If validated in larger trials, this approach could reduce dependence on donor tissue altogether. Artificial corneas — keratoprostheses such as the Boston KPro — serve patients who have failed multiple grafts, though long-term complication rates remain significant.

Frequently Asked Questions

How long does a corneal transplant last?

Graft longevity varies by technique and diagnosis. First-time penetrating keratoplasty grafts for keratoconus can survive 20 years or more, while grafts in high-risk eyes may fail within a few years. Endothelial keratoplasty grafts show strong survival at 5 to 10 years, with longer-term data still accumulating.

Is corneal transplant surgery painful?

The procedure is typically performed under local anesthesia with sedation. Postoperative discomfort is generally mild — more of a gritty, foreign-body sensation than sharp pain — and usually manageable with prescribed drops and over-the-counter analgesics.

What is the difference between DSAEK and DMEK?

Both replace the endothelial layer, but DMEK transplants a thinner graft (Descemet membrane and endothelium only), which tends to produce better final visual acuity. DSAEK includes an additional thin layer of stroma, making the tissue easier to handle surgically but slightly less optically ideal.

Can a corneal transplant be repeated if it fails?

Regrafting is possible and performed regularly. Success rates for repeat transplants are lower than for primary grafts, particularly if the cause of failure was immunologic rejection. Careful preoperative assessment and intensified postoperative immunosuppression improve outcomes in regraft cases.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)

Continue Reading

Next Oculoplastic Surgery: Eyelid, Orbital, and Lacrimal Procedures [standard]